Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Surfactant-Derived Lipid Nanoparticles Enable mRNA Delivery
2026-04-13
This study reports the development of dual-component lipid nanoparticles (LNPs) based on surfactant-derived quaternary ammonium compounds for efficient intracellular delivery of messenger RNA to macrophages. The approach addresses a major barrier in non-viral mRNA delivery, suggesting new strategies for gene engineering of hard-to-transfect immune cells.
-
NMDA Receptor Control of Cav2.1 in Parvalbumin Interneuron M
2026-04-13
This study reveals how NMDA receptor function in developing neocortical parvalbumin interneurons orchestrates the recruitment of Cav2.1 (P/Q-type) calcium channels to regulate GABAergic synaptic transmission. The findings clarify molecular mechanisms underlying excitation-inhibition balance, implicating early-life NMDA signaling in the pathogenesis of schizophrenia-like phenotypes.
-
Autophagy–Metastasis Prognostic Signature in Colorectal Canc
2026-04-12
Bai et al. (2026) present a rigorously validated prognostic signature for colorectal cancer based on autophagy and liver metastasis gene expression, integrating bulk and single-cell transcriptomic data. This signature not only surpasses traditional risk factors for prediction, but also reveals mechanistic links between autophagy, immune microenvironment remodeling, and therapeutic resistance.
-
BMS-777607: Translational Leverage in MET Pathway Inhibition
2026-04-12
This article provides a mechanistic and strategic analysis of BMS-777607, a highly selective c-Met inhibitor, for translational researchers. By integrating new findings from stem cell-derived platelet production and cancer metastasis models, the discussion highlights optimized workflows, protocol parameters, and the unique cross-domain relevance of BMS-777607, with perspective on how this expands beyond traditional oncology applications. Evidence-based recommendations are presented for experimental design, with critical citations and workflow guidance.
-
Berberrubine Chloride: Workflow Optimization in Cancer Resea
2026-04-11
Berberrubine chloride (9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride) is revolutionizing in vitro and in vivo oncology workflows with its selective multi-target inhibition and robust solubility in DMSO. This article details actionable protocols, troubleshooting strategies, and the translational edge offered by APExBIO’s high-purity research chemical.
-
Faropenem Sodium: Penem Antibiotic for Advanced Infection Mo
2026-04-11
Faropenem sodium stands out as a penem antibiotic with superior anaerobic and broad-spectrum activity, enabling robust workflows in antibiotic resistance and cell wall inhibition studies. This guide translates reference-driven insights and practical troubleshooting tips into actionable protocols for researchers.
-
FURA-2AM: Practical Use as a Fluorescent Calcium Indicator
2026-04-10
FURA-2AM is a cell-permeable fluorescent calcium indicator designed for precise intracellular Ca2+ measurement via ratiometric fluorescence microscopy. It is best suited for live-cell calcium signaling studies where quantifiable, artifact-minimized data is required. FURA-2AM should not be used in workflows requiring aqueous solubility or long-term dye storage.
-
Applied Insights with EZ Cap™ Human PTEN mRNA (ψUTP): Enh...
2026-04-10
EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to robustly restore tumor suppressor PTEN function, enabling precise PI3K/Akt pathway inhibition and resistance reversal in advanced cancer models. Its pseudouridine modification and Cap 1 structure deliver superior stability, translational efficiency, and reduced immunogenicity—making it a best-in-class mRNA reagent for translational gene expression studies.
-
From Mechanism to Medicine: Strategic Advances in Caspase...
2026-04-09
This thought-leadership article explores the mechanistic foundations and translational opportunities enabled by sensitive detection of DEVD-dependent caspase-3 activity using the Caspase-3 Colorimetric Assay Kit. By bridging apoptosis biology, real-world workflow optimization, and emerging insights from ER stress and immune regulation in macrophages, we provide translational researchers with actionable strategies for robust biomarker quantification and discovery.
-
Caspase-3 Colorimetric Assay Kit: Unveiling Apoptosis Pat...
2026-04-08
Explore the Caspase-3 Colorimetric Assay Kit for advanced DEVD-dependent caspase-3 activity detection. This article reveals unique strategies for integrating apoptosis assays in neuroimmune research, highlighting mechanistic insights and novel biomarker applications.
-
Caspase-3 Colorimetric Assay Kit: Unveiling Apoptosis Pat...
2026-04-08
Explore how the Caspase-3 Colorimetric Assay Kit enables precise DEVD-dependent caspase-3 activity detection, advancing apoptosis biomarker discovery and pathway analysis. This article delves into mechanistic insights and unique research applications beyond routine cell apoptosis assays.
-
Equimolar dNTP Solutions as Pillars of Translational DNA ...
2026-04-07
This thought-leadership article explores the pivotal role of equimolar dNTP solutions—specifically the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO—in advancing molecular biology and translational research. By interweaving mechanistic understanding, experimental evidence, and strategic recommendations, we highlight how precision nucleotide mixtures underpin robust DNA synthesis, PCR, and DNA delivery workflows, even as new insights challenge established protocols. Drawing on landmark studies and recent innovations, the discussion extends beyond technical specifications to frame dNTP formulation as a strategic lever for workflow reliability, data reproducibility, and innovation at the clinical interface.
-
ω-Agatoxin IVA TFA: Structural Mechanisms and Translation...
2026-04-07
Discover the structural basis and translational potential of ω-Agatoxin IVA TFA, a highly specific P/Q-type voltage-gated calcium channel blocker. This in-depth article explores its unique mechanism, therapeutic promise, and advanced research applications for neuroprotection and epilepsy.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Molecular Innovation for ...
2026-04-06
Discover how EZ Cap™ Human PTEN mRNA (ψUTP) drives advanced cancer research through enhanced mRNA stability, reduced immunogenicity, and precise PI3K/Akt pathway inhibition. This in-depth review explores novel mechanistic insights, translational opportunities, and strategic applications for molecular biology and gene therapy studies.
-
Caspase-3 Colorimetric Assay Kit: Unveiling DEVD-Dependen...
2026-04-06
Explore the advanced applications of the Caspase-3 Colorimetric Assay Kit for DEVD-dependent caspase-3 activity detection in apoptosis and disease research. This in-depth article uniquely integrates mechanistic insights, novel cancer biology, and expert assay optimization strategies.